Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05849155 · ClinicalTrials.gov registry record

Barriers and Facilitators of Parent-Child Communication in Children With Cancer Predisposition

A clinical trial of Genetic Predisposition, sponsored by St. Jude Children's Research Hospital.

Recruiting
Registry status
125
Enrollment target
1
Study location

NCT05849155: Recruiting study of Genetic Predisposition, sponsored by St. Jude Children's Research Hospital.

NCT05849155 is a study of Genetic Predisposition that is actively recruiting participants, run by St. Jude Children's Research Hospital. The registered enrollment target is 125 participants, below the 3,511-participant average among 14 other Genetic Predisposition trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05849155, a study of Genetic Predisposition, is actively recruiting participants, sponsored by St. Jude Children's Research Hospital.

RECRUITING
Registry status
125 participants
Enrollment target
1
Study location

Study Summary

Testing children, adolescents, and young adults (CAYA) for a genetic risk for cancer can help with early prevention and detection of cancers through regular follow-ups and medical care. After receiving genetic test results, CAYA may not accurately understand what their results mean, and parents are often unsure about talking with their CAYA about their genetic risk for cancer. By understanding how parents communicate with their CAYA, the investigators can improve future genetic education to reduce cancer risk. Primary Objectives: * Identify qualities of parent-CAYA (child, adolescent, and young adults) communication about CAYAs' genomic cancer risk, and their association with CAYAs' psychosocial and prevention outcomes. * Examine the association between sociodemographic, cancer-related, and psychosocial factors and parent-CAYA communication regarding CAYAs' genomic risk for cancer. * Identify barriers and facilitators of parent-CAYA communication regarding CAYAs' genomic risk for cancer.

Primary Outcome

Multiple regression models will be conducted to assess whether demographic and clinical factors significantly relate to quality and style of observed communication variables, as assessed using the Iowa Family Interaction Rating Scales. Multiple regression models will also be conducted to investigate whether general family communication, parent adjustment, parent genetic knowledge, parent sense of efficacy, and perception of children as less vulnerable (as assessed by parent and CAYA reported me

Conditions Studied

Study Locations (1)

Tennessee

  • St. Jude Children's Research Hospital - Memphis

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2023-12-12
Est. Completion 2028-10

What NCT05849155 shows while recruiting

NCT05849155 is an observational study that tracks outcomes without assigning an intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 3,511-participant average among 14 other Genetic Predisposition trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Genetic Predisposition appearing as the primary indexed condition, and to 0 interventions.

NCT05849155 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT05849155 about?

NCT05849155 is a clinical study titled "Barriers and Facilitators of Parent-Child Communication in Children With Cancer Predisposition". Testing children, adolescents, and young adults (CAYA) for a genetic risk for cancer can help with early prevention and detection of cancers through regular follow-ups and medical care. After receiving genetic test results, CAYA may not accurately understand what their results mean, and parents are ...

What is the current status of trial NCT05849155?

This trial is currently recruiting. The enrollment target is 125 participants. The study started on 2023-12-12. Estimated completion is 2028-10.

What conditions does trial NCT05849155 study?

This clinical trial studies the following conditions: Genetic Predisposition.

Who is sponsoring clinical trial NCT05849155?

This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05849155 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Genetic Predisposition

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05849155's enrollment target sits among peer trials

125 10th of 14 higher than 4 of 14 other Genetic Predisposition trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Genetic Predisposition trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02717039 · 125 participants

    Pharmacogenomics of Heparin-Induced Thrombocytopenia

  • NCT02763033 · 125 participants · Phase 2

    Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients

  • NCT02793999 · 125 participants

    Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia

  • NCT03003299 · 125 participants · NA

    PARTNER 3 Trial - Aortic Valve-in-Valve

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05849155, the US trial registry maintained by the National Library of Medicine. NCT05849155 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.